• OPEN AN ACCOUNT
Indian Indices
Sensex
78,542.44 43.27
( 0.06%)
Global Indices
Nasdaq
54,056.75 150.65
(0.28%)
Dow Jones
7,778.11 47.15
(0.61%)
Hang Seng
66,870.65 1,263.94
(1.93%)
Nikkei 225
10,869.98 -31.11
(-0.29%)
Forex
USD-INR
95.20 0.13
(0.14%)
EUR-INR
109.83 0.08
(0.08%)
GBP-INR
128.13 0.14
(0.11%)
JPY-INR
0.60 0.00
(-0.12%)

EQUITY - MARKET SCREENER

Lyka Labs Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
500259
INE933A01014
24.1923243
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
LYKALABS
0
244.46
EPS(TTM)
Face Value()
Div & Yield %
0
10
0
 
( Cr)
ParticularsJun 2026 ( Cr)Mar 2026 ( Cr)Dec 2025 ( Cr)
Gross Sales42.3128.0330.73
Other Operating Income0.000.000.00
Other Income 0.420.511.37
Total Income42.7328.5432.09
Total Expenditure 37.7255.5328.83
PBIDT5.01-26.993.26
Interest 1.010.870.82
PBDT4.00-27.862.45
Depreciation2.012.042.15
Tax0.000.340.00
Fringe Benefit Tax0.000.000.00
Deferred Tax-0.11-0.470.00
Reported Profit After Tax2.10-29.770.29
Extra-ordinary Items 0.00-22.750.00
Adjusted Profit After Extra-ordinary item2.10-7.020.29
EPS (Unit Curr.)0.58-8.240.08
EPS (Adj) (Unit Curr.)0.58-8.240.08
Calculated EPS (Unit Curr.)0.58-8.240.08
Calculated EPS (Adj) (Unit Curr.)0.58-8.240.08
Calculated EPS (Ann.) (Unit Curr.)2.32-32.940.33
Calculated EPS (Adj) (Ann.) (Unit Curr.)2.32-32.940.33
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity36.1536.1535.69
Reserve & Surplus0.000.000.00
Face Value10.0010.0010.00
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
PBIDTM(%)11.84-96.2910.61
PBDTM(%)9.45-99.397.97
PATM(%)4.96-106.210.94